Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
China · Delayed Price · Currency is CNY 36.02
-0.61 (-1.67%)
Oct 16, 2026, 3:00 PM CST
SHA:600211 Market Cap
SHA:600211 has a market cap or net worth of 11.47 billion as of October 16, 2026. It is the 7,342nd most valuable company in the world and the 1,411th biggest in China. Its market cap has decreased by 26.30% in one year.
Market Cap
11.47B
Enterprise Value
9.21B
Revenue
2.89B
Global Rank
Country Rank
#1,411 China
PE Ratio
11.79
ChartMarket Cap Chart
Since October 20, 1999, SHA:600211's market cap has increased from 1.45B to 11.47B, an increase of 691.82%. That is a compound annual growth rate of 7.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 11.47B | -16.40% |
| Dec 31, 2025 | 13.71B | 15.19% |
| Dec 31, 2024 | 11.91B | -1.59% |
| Dec 29, 2023 | 12.10B | 35.86% |
| Dec 30, 2022 | 8.91B | -31.40% |
| Dec 31, 2021 | 12.98B | -22.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Hepalink Pharmaceutical Group | 12.35B |
| Guobang Pharma | 12.23B |
| Henan Lingrui Pharmaceutical | 11.94B |
| Beijing Aosaikang Pharmaceutical | 11.81B |
| Zhejiang Medicine | 11.49B |
| Porton Pharma Solutions | 11.30B |
| Shanghai Shyndec Pharmaceutical | 11.17B |
| Zhejiang CONBA Pharmaceutical | 10.84B |